Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Cambrex Corporation    CBM   US1320111073

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
03/20/2015 03/23/2015 03/24/2015 03/25/2015 03/26/2015 Date
36.69(c) 35.46(c) 35.81(c) 33.53(c) 34.88 Last
530 090 394 218 314 072 537 182 574 059 Volume
+2.92% -3.35% +0.99% -6.37% +4.03% Change
More quotes
Financials ($)
Sales 2015 427 M
EBIT 2015 80,0 M
Net income 2015 54,5 M
Debt 2015 -
Yield 2015 -
Sales 2016 458 M
EBIT 2016 87,6 M
Net income 2016 63,7 M
Debt 2016 -
Yield 2016 -
PER 2015 19,61
PER 2016 16,77
Capi. / Sales 2015 2,46x
Capi. / Sales 2016 2,29x
Capitalization 1 049 M
More Financials
Company
Cambrex Corp. is a life sciences company that provides products, services and technologies to accelerate and improve the development and commercialization of new and generic therapeutics.It supplies its products and services worldwide to innovator and generic pharmaceutical companies.The company's... 
Sector
Pharmaceuticals
Calendar
04/29Shareholder meeting
More about the company
Latest news on CAMBREX CORPORATION
03/12 CAMBREX : Receives 2015 Contract Manufacturing Organization (CMO) Leadership Awa..
02/09 CAMBREX : Announces Expansion of Large Scale API Capacity
02/09 CAMBREX : Reports Fourth Quarter And Full Year 2014 Financial Results
02/09 CAMBREX : Announces Expansion of Large Scale API Capacity
02/09 CAMBREX : Reports Fourth Quarter and Full Year 2014 Financial Results
02/06 CAMBREX : NYSE stocks posting largest volume increases
02/06 CAMBREX : Management's Discussion and Analysis of Financial Condition and Result..
02/06 CAMBREX : Results of Operations and Financial Condition, Financial Statements an..
More news
Sector news : Pharmaceuticals - NEC
12:50p SANDISK : Nasdaq 100 Movers: SNDK, CELG
12:30p NOVO NORDISK A/S : Novo Nordisk has decided to resubmit the New Drug Application..
12:25p NOVO NORDISK A/S : A/S : has decided to resubmit the New Drug Applications of Tr..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
03/04 NASDAQ BREAKS 5000 : Is A New High On The Horizon?


Comments 
Advertisement
Chart CAMBREX CORPORATION
Duration : Period :
Cambrex Corporation Technical Analysis Chart | CBM | US1320111073 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF